JPRN-UMIN000000599
Completed
Phase 2
A phase II study of preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer - A phase II study of preoperative concurrent chemoradiotherapy for non-small-cell lung cancer
Setouchi Lung Cancer Group0 sites1 target enrollmentFebruary 8, 2007
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- resectable locally advanced non small cell lung cancer
- Sponsor
- Setouchi Lung Cancer Group
- Enrollment
- 1
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
npublished
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •a) Malignant pleuritis or malignant pericarditis. b) Pleural dissemination. c) Positive suplra calavicle nodes. d) Active double cancer. The definition of inactive is that disease\-free interval is more than 5 years. However, patients who have history of chemotherapy or thoracic irradiation are not acceptable. e) Patients with severe complications. 1\) Pulmonary fibrosis recognized with computed tomography scanning. 2\)Severe heart disease.(Uncontrollable angina or myocardial infarction within the past 3 months) 3\) Uncontrollable Diabetes Mellitus. 4\) Severe infectious disease 5\) Other unsuitable patient judged by a physician. f) Women during pregnancy or lactating.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A phase II study of preoperative concurrent chemoradiotherapy with TS-1/ Oxaliplatin in patients with locally advanced rectal cancer(PerSeUS-RC01)locally advanced rectal cancerJPRN-UMIN000011861PerSeUS:Perpetual Study estimated-by United Sections in Gifu40
Recruiting
Phase 2
A phase II study of preoperative concurrent chemoradiation therapy for patients with locally advanced rectal cancerectal cancerJPRN-UMIN000004104Hamamatsu University School of Medicine, Second department of Surgery30
Recruiting
Phase 2
A Phase II study of preoperative concurrent chemoradiotherapy with TS-1 in patients with locally advanced lower rectal cancer.ocally-advanced lower rectal cancerJPRN-UMIN000006242ara Hospital Kinki University Faculty of Medicine20
Unknown
Phase 2
Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal CancerRectal NeoplasmNeoadjuvant TherapyNCT00506623National Cancer Center, Korea48
Recruiting
Phase 2
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic CancerPancreas AdenocarcinomaResectable Pancreatic CancerNCT03492671Loma Linda University30